NCT02654912View on ClinicalTrials.gov

Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration

PHASE4CompletedINTERVENTIONAL

Enrollment

8,682

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

July 31, 2020

Conditions

Malaria

Interventions

DRUG

Reactive Focal Drug Administration

This is the experimental arm and is described by a reactive response to passively detected index case of malaria. The reactive response consists of treating all individuals within a defined radius of each RDT-confirmed incident malaria case with dihydroartemisinin-piperaquine (DHAP).

Trial Locations (1)

Unknown

Southern province medical office, Choma

All Listed Sponsors

collaborator

Ministry of Health, Zambia

OTHER_GOV

collaborator

AKROS Global Health

UNKNOWN

lead

PATH

OTHER

NCT02654912 - Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration | Biotech Hunter | Biotech Hunter